Information Library

Results for: Enrollment & retention - Clinical Services - Our Expertise

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Partnering is Key to Maximizing Rewards in Emerging Markets

    Press Release — September 27, 2011 – While biopharmaceutical spending in emerging markets is growing at double-digit rates – much faster than in developed nations – opportunities in “pharmerging” countries must be balanced with accompanying costs and risks of entering new markets.

  • Accelerated Access

    Case Study — June 2, 2010
    Quintiles drew on extensive experience, a thorough understanding of the disease state and a myriad of tools in the Quintiles recruitment arsenal for a comprehensive solution to reach the right patients at the right time.

  • FDA Requirements for Clinical Studies in Pediatric Patients

    White Paper — April 1, 2010
    FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy

  • Propelling Pediatric Research

    Case Study — April 1, 2010
    Learn how Quintiles' global reach and rigorous research standards dramatically cut recruitment from 4 years to 1 in a childhood immunology study

  • Boosting Pediatric Enrollment

    Case Study — April 1, 2010
    Read how Quintiles took a nasal influenza vaccine trial from the brink of delay to full recruitment in only two weeks.

  • Data-Driven Patient Recruitment

    White Paper — March 23, 2010
    Under pressure to deliver more evidence faster, drug developers are constantly searching for more patients for clinical trials.

  • Anticipating the Challenge

    Case Study — March 3, 2010
    Extensive experience and expertise in Alzheimer's Disease accelerated outcomes in multi-country Phase II study.

  • Advancing Innovation

    Case Study — March 3, 2010
    Prescreening and safety measures simplified a Phase II study of a four-dose vaccine that required multiple rating scales.

  • Alzheimer's Inroads

    Case Study — March 3, 2010
    A global, multi-site Phase III trial required a large number of patients with a specific number of sites and patients at each site.

  • Trumping Expectations

    Case Study — March 1, 2010
    Quintiles sails past recruitment hurdles with tailored approaches that build momentum

Page 1 of 2 (13 results)

Subscribe to Email Based on Your Interests

Set preferences